You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 2
  • CT-03 Phase 2 trial of induction therapy with anti-CD20 (rituximab) followed by maintenance therapy with anti-BAFF (belimumab) in patients with active lupus nephritis

Citation Tools

Article menu

Download PDFPDF

Clinical Trials
CT-03 Phase 2 trial of induction therapy with anti-CD20 (rituximab) followed by maintenance therapy with anti-BAFF (belimumab) in patients with active lupus nephritis
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Aranow C, Dall’Era M, Byron M, et al
CT-03 Phase 2 trial of induction therapy with anti-CD20 (rituximab) followed by maintenance therapy with anti-BAFF (belimumab) in patients with active lupus nephritis
Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-lsm.75